MedTrace Logo

Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2

NCT04337424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 627

Last updated 2020-11-04

No results posted yet for this study

Summary

Coronavirus disease 2019 or COVID-19 is a highly contagious infectious disease. Symptoms of the disease are non-specific (fever, cough, dyspnea and fatigue), common with many seasonal viruses, which complicates the diagnosis. For mild forms, which represent the vast majority of cases, hospitalization is not necessary and treatment is symptomatic. However in more severe cases, hospitalization is required and sometimes even admission to an intensive care unit.

Several diagnostic tests are already available, but they require, in all cases, the intervention of qualified health personnel to carry out the sample, which includes a risk of contagion and an expensive and time-consuming laboratory analysis and reagents. These tests are therefore not very suitable for massive screenings.

We want to evaluate the performance of a detection test performed on a salivary sample in the diagnosis of SARS-CoV-2. This test will be non-invasive, performed without any analytical device and will restore its qualitative result "infected versus non-infected" in less than 1 hour (30min objective).

Conditions

Interventions

DIAGNOSTIC_TEST

Sampling salivary

Collection of 1 to 2 ml of saliva

Sponsors & Collaborators

  • societe SkillCell - 97198 Jarry

    collaborator UNKNOWN

  • CNRS Alcediag UMR9005 - societe Sys2Diag - 34184 Montpellier

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • REYNES Jacques, PU PH · Montpellier Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2020-10-07
Completion
2020-10-07

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04337424 on ClinicalTrials.gov